1. Home
  2. AROW vs ANL Comparison

AROW vs ANL Comparison

Compare AROW & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

HOLD

Current Price

$37.37

Market Cap

600.9M

Sector

Finance

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$16.35

Market Cap

703.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROW
ANL
Founded
1851
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
600.9M
703.3M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
AROW
ANL
Price
$37.37
$16.35
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$28.00
$20.00
AVG Volume (30 Days)
94.8K
551.4K
Earning Date
04-30-2026
04-10-2026
Dividend Yield
3.21%
N/A
EPS Growth
49.72
N/A
EPS
2.65
N/A
Revenue
N/A
N/A
Revenue This Year
$33.36
$36.02
Revenue Next Year
$18.26
N/A
P/E Ratio
$14.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.36
$0.88
52 Week High
$38.09
$16.97

Technical Indicators

Market Signals
Indicator
AROW
ANL
Relative Strength Index (RSI) 77.65 74.22
Support Level $31.14 $1.36
Resistance Level N/A N/A
Average True Range (ATR) 0.82 2.40
MACD 0.26 0.75
Stochastic Oscillator 85.08 97.83

Price Performance

Historical Comparison
AROW
ANL

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: